Podcasts about Prevalence

In this episode with Mitchell Selhorst, we discuss a recent paper in which he was lead author looking at standard care of spondylolysis. We explore:  ·       What is spondylolysis?·       Prevalence of spondylolysis·       Standard care of spondylolysis·       Evidence based care of spondylolysis e.g. “Immediate functional progression program”·       Role of education in this population

Depression is often treated as a single condition. But two people with the same diagnosis can have completely different underlying causes. On this episode of The Dr. Hyman Show, I'm rejoined by Dr. James Greenblatt to explore why depression may be less of a disease and more of a signal that something deeper is going on. We discuss how a root-cause approach can uncover what's driving symptoms and why finding what's beneath them matters. Watch the full conversation on YouTube or listen wherever you get your podcasts. We discuss: Could nutrient deficiencies, inflammation, or gut issues be contributing to symptoms of depression What tests can help uncover the biological factors that may be affecting mood and mental health Why can two people with depression have different root causes—and require different solutions How do blood sugar imbalances, hormone changes, and metabolic health influence the brain What should you know about antidepressants, tapering, and addressing the factors that may affect recovery Hope doesn't come from ignoring symptoms—it comes from understanding them. Sometimes the most important question isn't "What's wrong with me?" but "What might my body be trying to tell me?" One of the key themes in this conversation is that mental health is deeply connected to what's happening throughout the body. In my Brainshaping Academy, you'll learn how to support the biological systems that shape cognitive, emotional, and mental well-being. View Show Notes From This Episode Depression symptoms aren't always just “in your head.” Dr. Hyman's Brainshaping Academy shows how your gut, immune system, and nutrient levels may be responsible—and what you can do about it. → https://drhyman.com/products/brainshaping?utm_source=dr_hyman_show&utm_medium=newsletter&utm_campaign=may_27&utm_content=link Get Free Weekly Health Tips from Dr. Hyman https://drhyman.com/pages/picks?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Sign Up for Dr. Hyman's Weekly Longevity Journal https://drhyman.com/pages/longevity?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Join the 10-Day Detox to Reset Your Health https://drhyman.com/pages/10-day-detox Join the Hyman Hive for Expert Support and Real Results https://drhyman.com/pages/hyman-hive This episode is brought to you by Seed, Made In Cookware, Perfect Amino, BON CHARGE, and Big Bold Health.Go to seed.com/hyman and use code 20HYMAN to get 20% off your first month.Visit madeincookware.com and use code HYMAN10 for 10% off your order.Go to bodyhealth.com and use code HYMAN20 to get 20% off your first order.Head to boncharge.com/hyman and use code HYMAN for 15% off.Go to bigboldhealth.com/drhyman and use code HYMAN15 to save 15% on your first order. (0:00) Antidepressants, Cooking at Home, and Introducing the Brain Shaping Academy (3:14) Prevalence of Depression and Personal Stories (4:27) Exploring Root Causes of Depression (5:07) Influential Figures and Orthomolecular Psychiatry (12:29) Gut Health, Gluten Sensitivity, and Brain Inflammation (20:22) Neuroinflammation and Root Causes of Depression (22:10) Biomarkers, Hormonal Imbalances, and Insulin Resistance (25:34) The Role of Toxins and Diagnostic Testing (31:15) Case Studies and Patient Stories (34:29) Challenges in the Mental Health System (37:05) Effectiveness of Antidepressants and Patient Resistance (43:17) Role and Need for Nutritional Lithium (45:00) Sponsor: Big Bold Health (46:00) Identifying Nutritional Lithium Need (47:13) Integrating Modalities and Supplements vs. Medications (48:04) Psychotherapy Methods and Addressing Root Causes (49:34) Dr. Greenblatt's Book and the Finding a Living Platform (51:03) Systematic Approach and Global Impact of Depression (52:39) Sharing, Disclaimer, and Closing Remarks

This episode of the Mind the Kids podcast features Dr. Joanne Park, clinical psychologist and Principal Investigator of the Parenting Resilient Kids (Park) Lab at Mount Royal University, Canada. Hosted by Clara Faria, the conversation explores emerging research on “climate worry” in early adolescence, drawing on Dr. Park's recent publication in Child and Adolescent Mental Health.Dr. Park examines whether concerns about climate change represent a distinct psychological construct or are simply an extension of generalised anxiety. The discussion unpacks the difference between affective climate worry—emotional responses to climate change—and cognitive climate worry, which reflects more developed fears about future impact. Importantly, the findings suggest that climate worry is not only common among younger adolescents but may also have unique associations with wellbeing, independent of general anxiety.The episode also highlights key developmental, social, and gender-related factors shaping how young people experience climate-related distress. Dr. Park discusses why girls and gender-diverse adolescents may report higher levels of climate worry, and considers how clinicians, educators, and parents can respond without over-pathologising what may be a rational reaction to the climate crisis.This conversation is essential listening for clinicians, researchers, and educators interested in child and adolescent mental health, particularly those working with anxiety, emotional development, and the psychological impact of global challenges. It also offers practical insight into how to support young people in managing climate-related concerns through adaptive coping and resilience-building strategies.Read the CAMH journal paper ‘Prevalence, conceptual distinctiveness, and cross-sectional correlates of climate worry in Canadian adolescents' - https://doi.org/10.1111/camh.70076Joanne L. Park, Audrey-Ann Deneault, Brae Anne McArthur, Suzanne Tough, Sheri MadiganFirst published: 18 February 2026Get a free CPD/CME certificate for listening to this podcast by registering for a FREE ACAMH Learn account at https://bit.ly/4fF4BBWVisit https://www.acamh.orgFacebook and LinkedIn search / ACAMHInstagram https://www.instagram.com/assoc.camhBluesky https://bsky.app/profile/acamh.bsky.socialX https://x.com/acamh

fWotD Episode 3310: Physella acuta Welcome to featured Wiki of the Day, your daily dose of knowledge from Wikipedia's finest articles.The featured article for Thursday, 28 May 2026, is Physella acuta.Physella acuta, also known as the European physa, tadpole snail, sewage snail, bladder snail, or acute bladder snail, is a species of small, air-breathing freshwater snail of the family Physidae. It originates from North America and was first described in 1805 by Jacques Philippe Raymond Draparnaud based on a specimen found in France. Like other physids, P. acuta presents a sinistral (left-coiling) shell as well as a unique set of muscles called the physid musculature that allows it to rapidly twist the shell as a defence mechanism.P. acuta is invasive on all continents except Antarctica and is considered by Dillon and colleagues (2002) as "the world's most cosmopolitan freshwater gastropod". Its first introduction outside North America likely occurred through the 18th-century cotton trade to Europe, while later spread mainly happened through the aquarium trade. The species can occupy diverse freshwater habitats and tolerates polluted as well as oxygen-poor environments. It can reproduce with other individuals and also self-fertilise. Due to its high reproductive rate and tolerance to habitat degradation, it frequently outcompetes native snail species. Prevalence of parasitic infections within invasive P. acuta populations is often low, but a 2024 study detected the human parasite Echinostoma (which causes a disease known as echinostomiasis upon infecting the gastrointestinal tract) in an individual from Rio de Janeiro, Brazil. In aquariums, P. acuta is usually introduced through ornamental plants and can become a "nuisance snail" due to its rapid reproduction. However, a controlled population in an aquarium can help clean up organic leftovers and control algal growth.This recording reflects the Wikipedia text as of 00:15 UTC on Thursday, 28 May 2026.For the full current version of the article, see Physella acuta on Wikipedia.This podcast uses content from Wikipedia under the Creative Commons Attribution-ShareAlike License.Visit our archives at wikioftheday.com and subscribe to stay updated on new episodes.Follow us on Bluesky at @wikioftheday.com.Also check out Curmudgeon's Corner, a current events podcast.Until next time, I'm standard Joanna.

Lipoprotein(a) or Lp(a) is suddenly all the rage because several drug companies are working on medications to lower this previously resistant form of cholesterol. Almost entirely genetic, unaffected by diet or lifestyle, it has numerous studies linking it to heart disease and aortic valve calcification. But it may not be the ticking time bomb some influencers like to claim.   Become a supporter of our show today either on Patreon or through PayPal! Thank you! http://www.patreon.com/thebodyofevidence/ https://www.paypal.com/donate?hosted_button_id=9QZET78JZWCZE   Email us your questions at thebodyofevidence@gmail.com.   Editor:    Robyn Flynn Theme music: “Fall of the Ocean Queen“ by Joseph Hackl Rod of Asclepius designed by Kamil J. Przybos Chris' book, Does Coffee Cause Cancer?: https://ecwpress.com/products/does-coffee-cause-cancer   Obviously, Chris is not your doctor (probably). This podcast is not medical advice for you; it is what we call information. References: The genetic nature of Lp(a) levels: https://pubmed.ncbi.nlm.nih.gov/1386087/ Prevalence of elevated Lp(a) in 500,000 US patients https://pubmed.ncbi.nlm.nih.gov/27659098/ Prevalence of elevated Lp(a) in 2.9 million Chinese adults https://pubmed.ncbi.nlm.nih.gov/40266173/ Prevalence of elevated Lp(a) in the INTERASPIRE study https://pubmed.ncbi.nlm.nih.gov/40436467/ Variation of Lp(a) by sex: https://pubmed.ncbi.nlm.nih.gov/27659098/ One of the many studies linking Lp(a) to cardiovascular disease https://pubmed.ncbi.nlm.nih.gov/33115266/ High Lp(a) and aortic stenosis: https://www.nejm.org/doi/full/10.1056/NEJMoa1109034 FH and Lp(a) https://pubmed.ncbi.nlm.nih.gov/32466883/ The ongoing Lp(a) trials https://familyheart.org/lpa-clinical-trials  

Gen Alpha has completely fragmented away from traditional TV, leaving advertisers scrambling to connect with kids and parents across YouTube, FAST channels, and gaming platforms.  This week, Mike sits down with Emma Witkowski, VP of Media Solutions at WildBrain, to unpack the massive market disconnect in children's media, the power of nostalgia in family co-viewing, and how upcoming privacy regulations like COPPA 2.0 are rewriting the rules of digital targeting. Key Highlights:

Is hypercortisolism the hidden culprit in a significant proportion of both difficult-to-treat diabetes and resistant hypertension? In part 4 of our special series, Dr. Neil Skolnik speaks with John Buse, MD to explore the effects of hypercortisolism, until just recently considered a vanishingly rare condition. This special episode is sponsored with support from Corcept. Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts, Amazon Music, Spotify, or your preferred podcast platform. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John Buse, MD, The Verne S. Caviness Distinguished Professor and director of the Diabetes Center at the University of North Carolina at Chapel Hill School of Medicine, a past president of medicine & science at the American Diabetes Association (ADA), and recipient of the ADA Outstanding Achievement in Clinical Diabetes Research Award Selected references: Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes. Diabetes Care April 2025 Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment. Diabetes Care June 2025 MOMENTUM: Hypercortisolism Present in 1-in-4 with Resistant Hypertension. HCP Live March 2026

PodChatLive 230: Reconceptulising the calf muscles, and osteoarthritis prevalence in professional footballersContact us: getinvolved@podchatlive.comLinks from this episode:Synergistic yet different: Rethinking the gastrocnemii as two functionally distinct musclesPrevalence of foot/ankle osteoarthritis and pain in retired male professional footballers compared to general population male controls

Anxiété et autisme, une réalité. On essaie de mieux comprendre, pour ensuite bien accompagner, et soulager.

In this episode of the Open Bedroom Podcast, I sit down with Jeff Abraham, CEO of Prometheus, a sexual wellness brand. Jeff shares how Prometheus developed their patented delay sprays and wipes to help men with premature ejaculation by reducing hypersensitivity—without numbing their partners. We dive into the "orgasm gap" between men and women, the importance of foreplay and communication, and why normalizing masturbation for men matters. Jeff also talks about female arousal gels, cock rings, and their Go Solo lotion. Throughout the episode, we focus on removing shame around sexual wellness and encourage couples to explore intimacy openly using the right tools.Unrealistic Expectations from Porn (00:00:01)Discusses how porn creates anxiety and unrealistic expectations about sex and performance.Origins of Promescent and PE Treatments (00:01:51)Jeff explains the founding of Promescent, early PE treatments, and the science behind their delay spray.How the Delay Spray Works (00:04:05)Details on the lidocaine-based spray, its unique formulation, and how it avoids numbing partners.The Orgasm Gap and Coping Mechanisms (00:06:14)Discusses the average duration of intercourse for men and women, the orgasm gap, and coping strategies.PE's Prevalence and Misdiagnosis (00:08:42)PE is more common than ED; misdiagnosis and psychological impacts are discussed.Anxiety, Confidence, and Sexual Performance (00:09:57)Explores the link between anxiety, confidence, and sexual performance in men.Impact of Porn on Sexual Expectations (00:13:38)How porn distorts expectations and increases anxiety for both men and women.Communication and Learning Your Partner (00:22:24)Importance of communication, understanding partner preferences, and overcoming shame in sexual relationships.Sex Education and Breaking Stereotypes (00:29:53)Lack of proper sex education, breaking myths about orgasms, and understanding female anatomy.Stigma and Physiology of Premature Ejaculation (00:56:48)Addressing stigma, physiological causes of PE, and the need for open discussion and solutions.Shop Promescent:https://www.promescent.com/Follow The Open Bedroom Podcast:https://www.instagram.com/theopenbedroompodcast/

AC joint injuries can quietly sabotage your performance, from dancers lifting arms overhead, actors performing stage combat, to singers holding props or standing for extended periods. In this episode of Performers Happiness in the Arts (PHARTS), Jenna Kantor, PT, DPT, dance medicine specialist and performer, explains how to identify, treat, and prevent AC joint injuries. Topics covered include: Prevalence in performers: 8–12% of dancers, 10–15% of actors, and 7–10% of singers (Micheli et al., Boston, 2016; Fryer, Australia, 2018; Ackermann et al., Sydney, 2017) Traumatic vs. overuse injuries Physical therapy strategies: manual therapy, scapular and rotator cuff strengthening, mobility restoration, and stage-specific return-to-dance training Prevention tips to maintain healthy, expressive arm lines

Welcome to Hacking Your ADHD. I'm your host, William Curb, and I have ADHD. On this podcast, I dig into the tools, tactics, and best practices to help you work with your ADHD brain. Today, I'm joined by Skye Waterson for our research recap series. In this series, we take a look at a single research paper, dive into what the paper says, how it was conducted, and try and find any practical takeaways. In this episode, we're going to be discussing a paper called "Prevalence, Patterns, and Predictors of Sleep Problems and Daytime Sleepiness in Young Adolescents with ADHD." And so this is a study that's investigating the high prevalence of sleep-related issues in adolescents with ADHD, and this paper is also trying to distinguish between, like, nighttime sleepiness disorders and daytime sleepiness. So the story here being that, hey, maybe ADHD might not be caused by poor sleep quality alone, but there are, like, strong links to other things like sluggish cognitive tempo, which we'll all get into. So how about that? Let's dive in. If you'd life to follow along on the show notes page you can find that at https://HackingYourADHD.com/293 https://tinyurl.com/56rvt9fr - Unconventional Organisation Affiliate link https://tinyurl.com/y835cnrk - YouTube https://www.patreon.com/HackingYourADHD - Patreon

Join Sue for an upcoming Live Virtual Workshop where you will learn from Sue practical tips & strategies to make a difference. In this episode, we will discuss: ✅ AuDHD: Autism and ADHD diagnosed together in same person. ✅ RSD: 98% with ADHD experience hypersensitivity to negative feedback. ✅ Prevalence: 50-70% of autistic people also have ADHD. ✅ Contradictions: AuDHD students need routine some days, variety others. ✅ Sensory: Often overlooked in ADHD but highly impactful. ✅ Strategies: Use visuals, kinesthetic learning, movement breaks consistently. ✅ Management: Label emotions and take thoughts to court. Read more about this podcast in the show notes found via the link below suelarkey.com.au/audhd-classroom-support-strategies Join the Facebook group specifically for this podcast www.facebook.com/groups/suelarkeypodcastcommunity/ Join my Neurodiversity Network suelarkey.com.au/neurodiversity-network/ Follow my Instagram account for regular tips www.instagram.com/sue.larkey/ To learn more about teaching or understanding ASD, please visit my website below. elearning.suelarkey.com.au

Survive Stroke Week is May 3-9, 2026: An annual event to promote stroke awareness and survival. Organized by The Society of NeuroInterventional Surgery (SNIS), this year’s focus is on the growing prevalence of stroke among younger age groups and the importance of immediate, lifesaving treatment. My guest is Dr. Jessica Campos, is a post graduate (year 7) neurosurgery resident at the University of California, Irvine, and an active mentor and resident board member of the Women in The American Association of Neurosurgeons and Congress of Neurological Surgeons Joint Section.See omnystudio.com/listener for privacy information.

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this Mind Moments episode, Greg Pontone, MD, Chief of Aging Behavioral and Cognitive Neurology at the University of Florida, joins the podcast to discuss the interplay between cognition and Parkinson disease, with a focus on how clinicians can better recognize and manage cognitive changes across the disease course. Pontone outlines the prevalence of early cognitive impairment, noting that a significant proportion of patients may present with subtle deficits at diagnosis, particularly in executive function and processing speed. The conversation explores the impact of commonly used medications on cognition, including anticholinergics and benzodiazepines, and how clinicians can balance therapeutic benefit with cognitive risk. Pontone also reviews current treatment strategies, including cholinesterase inhibitors and memantine, while emphasizing the importance of nonpharmacologic approaches such as structured routines and cognitive training. Additional discussion highlights the evolving role of biomarkers, the overlap between Parkinson disease and Alzheimer pathology, and the need for earlier recognition, better patient education, and continued research to improve long-term cognitive outcomes in this population.Looking for more Movement disorder discussion? Check out the NeurologyLive® Movement disorder clinical focus page.Episode Breakdown: 1:10 – Prevalence and early signs of cognitive impairment in Parkinson disease  2:30 – Medication-related cognitive effects and contributing drug classes 4:20 – Balancing therapeutic benefit vs cognitive risk in treatment decisions 6:05 – Current treatments for cognition, including pharmacologic and behavioral strategies 10:25 – Neurology News Network  13:00 – Role of biomarkers and Alzheimer overlap in Parkinson cognition 15:45 – Future priorities for advancing cognitive care and research in PD The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Clears Cala kIQ Plus for Essential Tremor and Parkinson Disease Hand Tremor FDA Issues Complete Response Letter for GTx-104 in Patients With Aneurysmal Subarachnoid Hemorrhage Satralizumab Meets Primary End Point in Phase 3 METEOROID Study in MOGAD Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

In this episode of One in Ten, host Teresa Huizar speaks with researcher Dr. Elizabeth Jeglic about preventing educator sexual misconduct, which has increased in schools even as abuse rates have declined in other youth-serving settings. Dr. Jeglic describes limited prior research since a 2004 Department of Education report and presents her team's survey of 6,600 recent high school graduates: 11.7% reported some form of educator sexual misconduct and about 1% reported contact abuse, with survivors reporting grooming as a near-universal pathway.  Time Stamps:  Time. Topic 00:00 Why Schools Are Riskier 01:44 Research Gap and New Data 03:13 What Counts as Misconduct 03:49 Grooming and Boundary Creep 08:32 Mentorship Versus Betrayal 09:58 High Risk Roles and Spaces 12:33 Prevalence and What It Means 14:03 Building a Culture of Safety 16:58 Training That Names Educators 19:03 Codes of Conduct That Work 19:37 No Touching Policies 20:57 Online Contact Boundaries 23:04 Pass the Trash Fixes 24:09 Supervision and Student Reporting 26:02 Progress and Patchwork Rules 27:25 Policy Reforms and Grooming Laws 30:29 Mandated Reporting Gaps 32:33 Why Data Stays Spotty 35:14 Parents Prevention Playbook 37:24 Research Updates and Wrap UpResourcesNational Blueprint | National Center to S.E.S.A.M.E.Support the showDid you like this episode? Please leave us a review on Apple Podcasts.

Alpha-gal syndrome is an emerging and often underrecognized allergy triggered by a tick bite that can cause delayed reactions to red meat and mammalian-derived products. In this episode, host Stacy Lauderdale is joined by clinical experts Zack Stacy and Kyna Henrici to unpack the science behind alpha-gal, its implications in healthcare settings, and the operational challenges providers face in managing this complex condition.    Guest Speakers:   Zachary Stacy, Pharm.D., MS, FCCP, BCPS  Clinical Pharmacy Specialist, Surgery  BJC Health   Kyna Henrici, RN  Medical Evidence Director - Cardiovascular  Vizient, Inc.    Host:    Stacy Lauderdale, Pharm.D., BCPS  AVP, Evidence-Based Medicine  Vizient, Inc.    00:05 – Introduction  Podcast introduction and welcome to VerifiedRx  00:14 – What is alpha-gal syndrome  Overview of alpha-gal syndrome  Delayed allergic reactions after eating red meat  Often linked to tick bites  00:48 – Meet the Guests   Zack Stacy, clinical pharmacy specialist  Kyna Henrici, medical evidence director  01:10 – Understanding the Allergy  Alpha-gal is a carbohydrate in nonprimate mammals that can trigger an allergy in humans  Key difference is delayed reaction timing  Symptoms are not always easy to trace   01:32 – How It Develops  Triggered by tick bites  Immune system produces IgE antibodies   Oral exposure to alpha-gal leads to delayed reactions  IV exposure to alpha-gal can cause immediate reactions  02:17 – Prevalence and Diagnosis Challenges  More common in Midwest and southern United States  Likely underdiagnosed  Often mistaken for general food allergies  Allergy may fade over time  03:07 – Risks in Healthcare Settings  Patient safety concerns beyond food  Mammalian components in medications and devices  Examples include heparin and surgical materials  03:44 – Hidden Medication Risks  Inactive ingredients can be animal derived  Examples include glycerin, lactose, amino acids, stearates  Difficult to identify and track  04:42 – Lack of Transparency  No centralized ingredient database  Sourcing can change frequently  Variability across manufacturers and batches  05:33 – Screening in Surgical Settings  Medication review at NDC level  Identification of active and inactive ingredients  May require contacting manufacturers  06:45 – Timing Challenges  Urgent procedures limit investigation time  Manufacturer responses may take days  Alternative medications often needed  07:14 – Identifying At Risk Patients  Many patients are unaware they have alpha-gal syndrome  Screening includes questions about dairy tolerance  Three patient categories used for evaluation  08:32 – Using Dairy as a Screening Tool   Dairy tolerance helps guide risk level  Food exposure typically higher than medication exposure  Determines need for deeper review  09:12 – Managing Emergencies  Focus shifts from avoidance to risk mitigation  Use of team communication and clear documentation  Preparation for unavoidable exposure  10:03 – Prevention and Preparedness  Stock alpha-gal safe medications when possible  Prepare for allergic reactions with standard treatments  10:47 – Team Based Care Approach  Collaboration across care teams is essential  Premedication strategies may be used  Close monitoring for reactions  11:11 – Gaps in Care  Limited visibility into product ingredients  Need for better labeling and transparency  11:33 – Need for Standardization  Call for clearer guidance and clinician education  Desire for centralized resource for medication ingredients  12:24 – Monitoring Challenges  CDC tracking decreased after privatization of testing  Cases likely still increasing  12:53 – Closing Remarks    Links and Resources: Alpha-gal Syndrome | Alpha-gal Syndrome | CDC    Subscribe Today!  Apple Podcasts  Spotify  YouTube  RSS Feed   

In this Supplement Ingredient Series episode, Nurse Doza breaks down glutathione — the master antioxidant your liver makes to fight inflammation, detox your body, and protect your brain. With roughly 1 in 4 people worldwide carrying a fatty liver, most are running on low reserves. Learn why glutathione is non-negotiable for energy, performance, and recovery — plus how to get your own vial to use at home. Featured Partner: SHED SHED delivers practitioner-grade glutathione in a vial you can use at home — the same master antioxidant Nurse Doza has administered through thousands of injections and IVs in clinical practice. Because the liver's ability to produce glutathione drops when it's fatty, inflamed, or overworked, supplementing directly is often the fastest way to restore energy, mental clarity, and detoxification pathways — exactly the mechanism discussed in this episode.

What is behind the rise in autism diagnoses? Join Jeremy Veenstra-VanderWeele, MD, professor of developmental neuropsychiatry at Columbia University, and JAMA Psychiatry Editor Dost Öngür, MD, PhD, as they discuss the history of autism spectrum disorder, the role that genetics and environmental factors play, the importance of early intervention in treatment, and more with JAMA Senior Editor Derek Angus, MD, MPH. Related Content: Autism—Understanding Diagnosis, Prevalence, and Treatment

In this episode, we're sharing a powerful PCOS success story of a client who went from struggling with fatty liver, low energy, and frustrating lab results to seeing meaningful improvements in her health, labs, and day-to-day wellbeing.We walk through what was really going on beneath the surface, the key nutrition and lifestyle shifts we focused on, and how she was able to create sustainable changes without extreme dieting or restriction.This episode is a reminder that progress is possible with the right support, strategy, and consistency - and that improving your labs often starts with small, realistic changes. In this episode, we cover:The connection between PCOS and fatty liverWhat her labs and symptoms looked like before vs. afterThe nutrition strategies that supported her energy and metabolismHow we approached sustainable habit changeWhat made the biggest difference in her day-to-day symptoms If you're ready to get personalized support for your liver function, hormones, gut health, and energy, our 1-on-1 nutrition coaching program is where we help you do this work every day. Apply through the link to start your own success story. Enjoyed the episode? We'd love to hear it! Leave a rating and review to support our show. ReferencesFranciscatto,M.E., Taniguchi,J.B., Wohlenberg,R., Riedi,I.L., & Oppermann,K. (2024). Prevalence and factors associated with non-alcoholic fatty liver disease among women with polycystic ovary syndrome. Revista Brasileira de Ginecologia e Obstetrícia,46, e-rbgo81.

What if the biggest threat to your dental practice isn't competition… but your own physical health? In this eye-opening episode, Dr. Len Tau sits down with Caitlin Parsons, dental hygienist and ergonomics and wellness consultant, to unpack how chronic pain and stress are silently impacting productivity, team dynamics, and patient experience. Caitlin shares her personal journey from nearly leaving dentistry due to pain to becoming a leader in helping dental professionals create sustainable, high-performing practices. From small ergonomic tweaks to integrating yoga therapy into your daily workflow, this conversation reveals how prioritizing wellness isn't just good for your body… it's a smart business move. If you've ever pushed through discomfort or felt burnout creeping in, this episode is your wake-up call to rethink how you care for yourself and your team.   What You'll Learn Why chronic pain is so common in dentistry and what causes it The connection between stress, posture, and patient experience How poor ergonomics impacts productivity and team performance Simple ergonomic adjustments that can make a big difference Why "pushing through pain" can cost you long-term The role of yoga therapy in managing stress and improving focus Practical ways to support your team's health without major investments How small daily habits can improve longevity in your career — Key Takeaways 00:49 Introduction & Episode Overview 02:55 Caitlin Parsons' Background & Journey 05:55 Prevalence of Pain in Dentistry 07:05 Signs of Poor Ergonomics 09:20 Impact of Stress & Chronic Pain on Performance 12:00 Real-Life Story on Patient Perception 14:36 Desk Ergonomics & Daily Habits 16:41 What is Ergonomic Optimization? 19:04 Small Changes That Make a Big Impact 20:55 The Danger of Ignoring Pain 23:40 Introduction to Yoga Therapy 26:55 Actionable Steps for Practice Owners 31:00 Lightning Round Q&A 34:40 How to Connect with Caitlin — Connect with Caitlin Website: thealignedhygienist.com Email: hello@thealignedhygienist.com Instagram: @thealignedhygienist

Great communication isn't about saying more—it's about making what you say matter.If we want to communicate more effectively, we need to treat communication less like a habit—and more like a series of intentional choices. In this special feed drop, we're featuring a conversation from the ⁠Masters of Scale⁠ podcast, where host ⁠Jeff Berman⁠ sits down with Stanford lecturer and ⁠Think Fast, Talk Smart ⁠host Matt Abrahams to explore what it really takes to communicate with intention.Most of us default to what feels natural—long-winded openings, generic pitches, or focusing on what we want to say. But as Matt explains, effective communication starts with the audience. Get to the point quickly. Focus on what's relevant. “Tell the time, don't build the clock.”From high-stakes presentations to job interviews and everyday interactions, Matt shares practical, science-backed strategies for showing up with clarity and confidence. Communication is something we all do every day—but doing it well, especially when it counts, takes intention. As this conversation makes clear, small shifts in how we prepare, structure, and deliver our message can make all the difference.Episode Reference Links:Jeff BermanMasters of ScaleConnect:Premium Signup >>>> Think Fast Talk Smart PremiumEmail Questions & Feedback >>> hello@fastersmarter.ioEpisode Transcripts >>> Think Fast Talk Smart WebsiteNewsletter Signup + English Language Learning >>> FasterSmarter.ioThink Fast Talk Smart >>> LinkedIn, Instagram, YouTubeMatt Abrahams >>> LinkedInChapters:(00:00) - Introduction (04:02) - Communication as a Skill (04:32) - The Impact of Communication (05:10) - Prevalence of Speaking Anxiety (07:11) - Techniques for Reducing Anxiety (09:46) - Core Principles: Repetition, Reflection, Feedback (10:53) - Communication in Education (12:03) - Opportunities to Improve Communication (14:26) - Presenting & Pitching Ideas (16:41) - Setting Clear Expectations (19:58) - Characteristics of Productive Meetings (24:13) - The Role of Repetition in Leadership (25:03) - Structured Preparation for Interviews (26:29) - The ADD Framework for Responses (27:57) - Asking Insightful Questions (29:17) - Defining Communication Objectives (32:23) - Adapting Messages to Different Formats (33:38) - Building Confidence in New Mediums (34:48) - Recovering from Cognitive Lapses (36:14) - The Pace, Space, Grace Framework (38:09) - Navigating Differing Perspectives (40:01) - Conclusion ********Thank you to our sponsors.  These partnerships support the ongoing production of the podcast, allowing us to bring it to you at no cost.Strawberry.me. Get 50% off your first coaching session today at Strawberry.me/smartJoin our Think Fast Talk Smart Learning Community and become the communicator you want to be. 

In this essential conversation, Dr. Linda Bluestein welcomes pelvic health physical therapist and dance science expert Dr. Brooke Winder to explore the often-hidden intersection of pelvic health, performance, and joint hypermobility. Dr. Winder shares her professional insights and personal history with urinary leakage as a young athlete, shedding light on why over a third of professional dancers and aerialists experience similar symptoms. The discussion unpacks the "hypermobility paradox", where muscles become chronically overactive to compensate for lax ligaments, and how this tension can lead to pelvic pain, incontinence, and sexual dysfunction. From the impact of under-fueling (REDs) to the surprising connection between jaw tension and the pelvic floor, this episode provides a roadmap for athletes and non-athletes alike to "zoom out" and find holistic strategies for recovery and resilience. Takeaways: The Hypermobility Paradox: People with lax connective tissue often have hyperactive pelvic floor muscles that work overtime to provide the stability their ligaments cannot. Prevalence in Performance: Around 34% of professional dancers and 40% of aerialists report urinary leakage, even those who have never been pregnant or given birth. The "Zoom Out" Method: Pelvic health is influenced by the entire body; issues in the jaw (TMJ), neck, and hips can directly contribute to pelvic floor tension and pain. REDs and Incontinence: Low energy availability (under-fueling) can weaken skeletal muscles, including the pelvic floor, and is now recognized as a health consequence of Relative Energy Deficiency in Sport. Autonomic Influence: The pelvic floor is highly responsive to the nervous system; conditions like POTS can trigger bladder urgency and disrupt coordination. Agency in Therapy: Pelvic floor PT does not always require an internal exam; many improvements can be made through external assessment, virtual coaching, and movement strategies Find the episode transcript here. Want more Dr. Brooke Winder? https://www.instagram.com/drbrookewinderpt/ Go to cozyearth.com and use my Promo Code: BENDYBOGO Go to AirDoctorPro.com and use promo code BENDY_ to get UP TO $300 off today! Want more Dr. Linda Bluestein, MD? Website: https://www.hypermobilitymd.com/ YouTube: https://www.youtube.com/@bendybodiespodcast Instagram: ⁠⁠⁠⁠https://www.instagram.com/hypermobilitymd/⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠https://www.facebook.com/BendyBodiesPodcast⁠⁠⁠⁠ X: ⁠⁠⁠⁠https://twitter.com/BluesteinLinda⁠⁠⁠⁠ LinkedIn: ⁠⁠⁠⁠https://www.linkedin.com/in/hypermobilitymd/⁠⁠⁠⁠ Newsletter: ⁠⁠⁠⁠https://hypermobilitymd.substack.com/ Shop my Amazon store ⁠⁠⁠ https://www.amazon.com/shop/hypermobilitymd Dr. Bluestein's Recommended Herbs, Supplements and Care Necessities: https://us.fullscript.com/welcome/hypermobilitymd/store-start For Appointments and Questions: RUVAEDSCenter@uvahealth.org UVA EDS: https://www.uvahealth.com/healthy-practice/advancing-care-through-ehlers-danlos-clinic UVA EDS FAQ: https://www.uvahealth.com/support/eds/faq UVA Pediatric Integrative Medicine: https://childrens.uvahealth.com/specialties/integrative-health Thank YOU so much for tuning in. We hope you found this episode informative, inspiring, useful, validating, and enjoyable. Join us on the next episode for YOUR time to level up your knowledge about hypermobility disorders and the people who have them. Join YOUR Bendy Bodies community at ⁠⁠https://www.bendybodiespodcast.com/⁠⁠. YOUR bendy body is our highest priority!⁠⁠ Learn more about Human Content at ⁠⁠⁠http://www.human-content.com⁠⁠⁠ Podcast Advertising/Business Inquiries: ⁠⁠⁠sales@human-content.com⁠⁠⁠ Part of the Human Content Podcast Network FTC: This video is not sponsored. Links are commissionable, meaning I may earn commission from purchases made through links Learn more about your ad choices. Visit megaphone.fm/adchoices

In this essential conversation, Dr. Linda Bluestein welcomes pelvic health physical therapist and dance science expert Dr. Brooke Winder to explore the often-hidden intersection of pelvic health, performance, and joint hypermobility. Dr. Winder shares her professional insights and personal history with urinary leakage as a young athlete, shedding light on why over a third of professional dancers and aerialists experience similar symptoms. The discussion unpacks the "hypermobility paradox", where muscles become chronically overactive to compensate for lax ligaments, and how this tension can lead to pelvic pain, incontinence, and sexual dysfunction. From the impact of under-fueling (REDs) to the surprising connection between jaw tension and the pelvic floor, this episode provides a roadmap for athletes and non-athletes alike to "zoom out" and find holistic strategies for recovery and resilience. Takeaways: The Hypermobility Paradox: People with lax connective tissue often have hyperactive pelvic floor muscles that work overtime to provide the stability their ligaments cannot. Prevalence in Performance: Around 34% of professional dancers and 40% of aerialists report urinary leakage, even those who have never been pregnant or given birth. The "Zoom Out" Method: Pelvic health is influenced by the entire body; issues in the jaw (TMJ), neck, and hips can directly contribute to pelvic floor tension and pain. REDs and Incontinence: Low energy availability (under-fueling) can weaken skeletal muscles, including the pelvic floor, and is now recognized as a health consequence of Relative Energy Deficiency in Sport. Autonomic Influence: The pelvic floor is highly responsive to the nervous system; conditions like POTS can trigger bladder urgency and disrupt coordination. Agency in Therapy: Pelvic floor PT does not always require an internal exam; many improvements can be made through external assessment, virtual coaching, and movement strategies Find the episode transcript here. Want more Dr. Brooke Winder? https://www.instagram.com/drbrookewinderpt/ Go to cozyearth.com and use my Promo Code: BENDYBOGO Go to AirDoctorPro.com and use promo code BENDY_ to get UP TO $300 off today! Want more Dr. Linda Bluestein, MD? Website: https://www.hypermobilitymd.com/ YouTube: https://www.youtube.com/@bendybodiespodcast Instagram: ⁠⁠⁠⁠https://www.instagram.com/hypermobilitymd/⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠https://www.facebook.com/BendyBodiesPodcast⁠⁠⁠⁠ X: ⁠⁠⁠⁠https://twitter.com/BluesteinLinda⁠⁠⁠⁠ LinkedIn: ⁠⁠⁠⁠https://www.linkedin.com/in/hypermobilitymd/⁠⁠⁠⁠ Newsletter: ⁠⁠⁠⁠https://hypermobilitymd.substack.com/ Shop my Amazon store ⁠⁠⁠ https://www.amazon.com/shop/hypermobilitymd Dr. Bluestein's Recommended Herbs, Supplements and Care Necessities: https://us.fullscript.com/welcome/hypermobilitymd/store-start For Appointments and Questions: RUVAEDSCenter@uvahealth.org UVA EDS: https://www.uvahealth.com/healthy-practice/advancing-care-through-ehlers-danlos-clinic UVA EDS FAQ: https://www.uvahealth.com/support/eds/faq UVA Pediatric Integrative Medicine: https://childrens.uvahealth.com/specialties/integrative-health Thank YOU so much for tuning in. We hope you found this episode informative, inspiring, useful, validating, and enjoyable. Join us on the next episode for YOUR time to level up your knowledge about hypermobility disorders and the people who have them. Join YOUR Bendy Bodies community at ⁠⁠https://www.bendybodiespodcast.com/⁠⁠. YOUR bendy body is our highest priority!⁠⁠ Learn more about Human Content at ⁠⁠⁠http://www.human-content.com⁠⁠⁠ Podcast Advertising/Business Inquiries: ⁠⁠⁠sales@human-content.com⁠⁠⁠ Part of the Human Content Podcast Network FTC: This video is not sponsored. Links are commissionable, meaning I may earn commission from purchases made through links Learn more about your ad choices. Visit megaphone.fm/adchoices

"Giving up smoking is the easiest thing in the world. I know because I've done it thousands of times". - Mark Twain While not an episode about nicotene withdrawal, this week we're talking all about research describing the phenomenon of relapse. Or is it renewal? Resurgence? All of the above? Basically any situation in which behavior, once thought removed from a repertoire, comes screaming back into reality. Regardless, teaching skills without planning for generalization to different contexts or being unsure when extinction will come into play is a recipe for disaster. Fortunately, some great researchers have been in the behvaior analysis kitchen trying to cook up the perfect meal of learning. This episode is available for 1.0 LEARNING CEU. Articles discussed this episode: Shahan, T.A. (2020). Relapse: An introduction. Journal of the Experimental Analysis of Behavior, 113, 8-14. doi: 10.1002/jeab.578 Mitteer, D.R., Greer, B.D., Fisher, W.W., Briggs, A.D., & Wacker, D.P. (2018). A laboratory model for evaluating relapse of undesirable caregiver behavior. Journal of the Experimental Analysis of Behavior, 110, 252-266. doi: 10.1002/jeab.462 Podlesnik, C.A., Ritchey, C.M., Muething, C., & Falligant, J.M. (2025). Different criteria affect prevalence of relapse of behavior targeted for treatment. Journal of Applied Behavior Analysis, 58, 225-231. doi: 10.1002/jaba.2927 Muething, C., Call, N., Ritchey, C.M., Pavlov, A., Bernstein, A.M., & Podlesnik, C.A. (2022). Prevalence of relapse of automatically maintained behavior resulting from context changes. Journal of Applied Behavior Analysis, 55, 138-153. doi: 10.1002/jaba.887 If you're interested in ordering CEs for listening to this episode, click here to go to the store page. You'll need to enter your name, BCBA #, the two episode secret code words, and answers to the knowledge check questions to complete the purchase. Email us at abainsidetrack@gmail.com for further assistance.

Clearly, according to a survey/study done in Sweden bad leadership is not under every rock. Only 42% of those surveyed don't trust their company's management team. Is the glass half full?

We’re excited today to launch our first episode in collaboration with the Irish Thoracic Society and their podcast series. The Irish Thoracic Society represents respiratory professionals throughout Ireland and is dedicated to championing excellence in the prevention, diagnosis, and clinical care of respiratory disease through its work in advocacy, education and research. In today’s episode, we explore the complex and often overlooked world of refractory chronic cough — a condition that can significantly impact patients' quality of life but is frequently misunderstood or underdiagnosed. With insights from leading respiratory specialists in Ireland and the United States, we discuss the latest thinking on diagnosis, management, and emerging treatments aimed at improving outcomes for patients and helping clinicians navigate this challenging area of respiratory medicine. Joining us are renowned experts Professor Lorcan McGarvey and Professor Brendan Canning, both internationally recognised leaders in respiratory medicine and cough research. Together, they share their perspectives on the neurobiology of chronic cough, the considerable morbidity experienced by patients, and how clinicians can approach diagnostic investigations more effectively. We also explore current treatment strategies and promising new therapies on the horizon as chronic cough increasingly gains recognition as a disease in its own right — rather than simply a symptom. Whether you’re a clinician, researcher, or simply interested in advances in respiratory medicine, this episode offers valuable insights into a condition that is finally receiving the attention it deserves. Meet Our Co-Hosts Marissa O'Callaghan is an Irish trained Respiratory fellow currently undertaking a post-doc fellow working in Erasmus MC Rotterdam in the Netherlands. She finished her Irish respiratory and Internal medicine training and Phd in 2025. Her areas of interest are interstitial and rare lung diseases. She enjoys clinical research, Med Ed, and dreaming up new medical innovations. Together with cohost Sandra Green, she founded the ITS podcast series in June 2024. Marissa O’Callaghan –LinkedIn Sandra Green is an Irish-trained respiratory fellow with a strong track record in climate advocacy and multidisciplinary sustainable initiatives, as co-founder of Irish Doctors for the Environment. She has an MSc in Leadership and Innovation in Healthcare at the Royal College of Surgeons Ireland (2023–2025). With Marisssa, she co-founded the Irish Thoracic Society Podcast Productions, launching the platform in 2024 to share knowledge, insights, and innovations in respiratory care. Sandra Green – LinkedIn Meet Our Guests Lorcan McGarvey is a professor of respiratory medicine at the University of Belfast, with a focus on the neurobiology of cough. His research has significantly contributed to the understanding of cough hypersensitivity syndrome and the development of new therapeutic strategies. Lorcan is a respected voice in the field, known for his collaborative work and dedication to advancing respiratory health. Brendan Canning is a distinguished researcher at Johns Hopkins University, specializing in the mechanisms of cough and airway diseases. His pioneering studies on neural pathways and receptor targets have paved the way for novel treatments in refractory chronic cough. Brendan’s expertise and innovative approach make him a key figure in the ongoing efforts to redefine chronic cough management. In This Episode The definitions and classifications of chronic cough, including unexplained, refractory, and unexplained refractory cough The importance of a thorough clinical history and focused diagnostics over exhaustive testing Common causes of chronic cough The role of personalized, multidisciplinary management—combining pharmacologic, speech therapy, and psychological support—to improve quality of life for even the most challenging patients. The concept of cough hypersensitivity syndrome and its role in refractory cases Evidence-based approach to treatment, including pharmacologic and non-pharmacologic options Emerging therapies on the horizon, including novel receptor modulators and neuromodulatory agents and ongoing clinical trials in this rapidly evolving field The impact of chronic cough on mental health, social life, and overall quality of life The importance of reframing chronic cough as a disease entity in its own right References and Further Reading Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet. 2008;371(9621):1364-1374. Gibson PG, Vertigan AE. Management of chronic refractory cough. BMJ. 2015;351:h5590. Matsumoto H, Kanemitsu Y, Ohe M, Tanaka H, Terada K, Nishi K, et al. Real-world usage and response to gefapixant in refractory chronic cough. ERJ Open Res. 2025;11(4):01037-2024. doi:10.1183/23120541.01037-2024. McGarvey LP, Birring SS. Cough hypersensitivity syndrome: a novel paradigm for understanding cough. Lancet Respir Med. 2014;2(8):647-656. Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Ribas CD, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55(1):1901136. Parker SM, Smith JA, Birring SS, Chamberlain-Mitchell S, Gruffydd-Jones K, Haines J, et al. British Thoracic Society clinical statement on chronic cough in adults. Thorax. 2023;78(Suppl 1):S3-S19. Smith JA, Woodcock A. Chronic cough. N Engl J Med. 2006;354(2):136-144. Song WJ, Dupont L, Birring SS, Chung KF, Dąbrowska M, Dicpinigaitis P, et al. Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study. ERJ Open Res. 2023;9(6):00618-2023. doi:10.1183/23120541.00618-2023. Song WJ, McGarvey L, Cho PSP, Mazzone SB, Chung KF, editors. Chronic cough. Sheffield: European Respiratory Society; 2025.

This podcast script debunks common misconceptions surrounding Nonverbal Learning Disorder (NLD), emphasizing that co-occurring conditions like ADHD, anxiety, and sensory sensitivities are the rule rather than the exception. Rather than viewing these traits as childhood-only deficits or a lack of intelligence, the script highlights that understanding the scientific facts empowers neurodivergent adults to build resilience and sharp problem-solving skills. Ultimately, embracing one's complete neurodivergent profile helps dismantle internalized blame, paving the way for strong self-advocacy and personalized systems of support.https://linktr.ee/JenniferPTTS?utm_source=linktree_profile_share⁠Articles Cited in This EpisodeMasking in Neurodivergent Adults: Psychological Costs and Coping Strategies – Autism Research, 2022https://onlinelibrary.wiley.com/doi/10.1002/aur.2478Neurodiversity: Definitions, Prevalence, and Clinical Implications – MDPI Social Sciences, 2023https://www.mdpi.com/2428-6200/3/4/91Emotional Awareness and Cognitive Strengths in NLD – Frontiers in Psychology, 2023https://www.frontiersin.org/articles/10.3389/fpsyg.2023.12345/fullSensory Hypersensitivity and Migraine: Mechanisms and Clinical Implications – ScienceDirect, 2020https://www.sciencedirect.com/science/article/pii/S003537872030463X

April showers are fun, especially after winter snowstorms. Fortunately, we've thawed out a whole mess of episodes for you to enjoy this month including our latest grab bag. But what about the themed episodes? Glad you asked! First, we'll be talking all about relapse which includes discussions of resurgence and renewal (see, aren't you glad you're learning about this?). Then we're joined by Armando Bernal to discuss how PECS could be a key component of building up our support of assent practices. Finally we get real and talk about peer mediation. The kind where children support skill acquisition of their with cues and praise. Not the other one. That'll get its own episode someday. All that and a new LISTENER POLL! Articles for April 2026 Golden Grab Bag (Spring Grab Bag 2026) Loomis, K. Morales, L., Yeo, Y., & Fienup, D.M. (2026). Turning the page: Increasing young children's preference for looking at and engaging with books. Journal of Applied Behavior Analysis, 59. doi: 10.1002/jaba.70051 Bigwood, L., Staples, E., & Sharp, R. (2026). Making preference assessments more acceptable and effective for people with dementia. Behavior Analysis in Practice. doi: 10.1007/s40617-025-01145-x Kaplan, B. A., Gelino, B. W., & Reed, D. D. (2018). A behavioral economic approach to green consumerism: Demand for reusable shopping bags. Behavior and Social Issues, 27, 20-30. doi: 10.5210/bsi.v.27i0.8003   Relapse Shahan, T.A. (2020). Relapse: An introduction. Journal of the Experimental Analysis of Behavior, 113, 8-14. doi: 10.1002/jeab.578 Mitteer, D.R., Greer, B.D., Fisher, W.W., Briggs, A.D., & Wacker, D.P. (2018). A laboratory model for evaluating relapse of undesirable caregiver behavior. Journal of the Experimental Analysis of Behavior, 110, 252-266. doi: 10.1002/jeab.462 Podlesnik, C.A., Ritchey, C.M., Muething, C., & Falligant, J.M. (2025). Different criteria affect prevalence of relapse of behavior targeted for treatment. Journal of Applied Behavior Analysis, 58, 225-231. doi: 10.1002/jaba.2927 Muething, C., Call, N., Ritchey, C.M., Pavlov, A., Bernstein, A.M., & Podlesnik, C.A. (2022). Prevalence of relapse of automatically maintained behavior resulting from context changes. Journal of Applied Behavior Analysis, 55, 138-153. doi: 10.1002/jaba.887   Assent and PECS w/ Armando Bernal Allen, L.L., Mellons, L.S., Syed, N., Johnson, J.F., & Bernal, A.J. (2024). Neurodiversity-affirming applied behavior analysis. Behavior Analysis in Practice. doi: 10.1007/s40617-024-00918-0 Doherty, A., Bracken, M., & Gormley, L. (2018). Teaching children with autism to initiate and respond to peer mands using picture exchange communication system (PECS). Behavior Analysis in Practice, 11, 279-288. doi: 10.1007/s40617-018-00311-8   Peer Mediation Morrison, L., Kamps, D., Garcia, J., & Parker, D. (2001). Peer mediation and monitoring strategies to improve initiations and social skills for students with autism. Journal of Positive Behavior Interventions, 3, 237-250. doi: 10.1177/10983007010030040 Beaulieu, L., Hanley, J.P., & Roberson, A.A. (2013). Effects of peer mediation on preschoolers' compliance and compliance precursors. Journal of Applied Behavior Analysis, 46, 555-567. doi: 10.1002/jaba.66 Grauvogel-MacAleese, A.N. & Wallace, M.D. (2010). Use of peer-mediated intervention in children with attention deficit hyperactivity disorder. Journal of Applied Behavior Analysis, 43, 547-551. doi: 10.1901/jaba.2010.43-547

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study. BMJ 2026. Discussion by:Guest:Susan Kucher, MDProgram Director - Abington Family Medicine Residency Program Jefferson Health2. Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes Results From the VESALIUS-CV Trial. JAMA. Discussion by:Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington3. Prevalence of Youth Overweight, Obesity, and Severe Obesity. JAMA Network Open. Discussion by:  Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington4. A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide. New England Journal of Medicine 2026. Discussion by:Guest:Griffin Johnson, MDResident - Abington Family Medicine Residency Program Jefferson HealthMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

This month: Multiple FDA regulatory decisions germane to dermatology, psoriasis and lupus; and Eosinophilic Fasciitis (EF) reminder and should you worry about fibromyalgia? Show Notes: 1. FDA Approves Icotrokinra for Plaque Psoriasis The FDA approved an oral IL-23 inhibitor, icotrokinra (Icotyde), for use in moderate-to-severe plaque psoriasis in adults and children 12 years of age and older who are candidates for systemic therapy or phototherapy, according to a https://t.co/q5b3TceFHx 2. FDA has approved secukinumab (Cosentyx) for use pediatric patients (aged 12yrs) with moderate to severe hidradenitis suppurativa  https://t.co/oX4LGU16QP 3. FDA has accepted the supplemental biologics license application for use of interleukin-23 inhibitor tildrakizumab (Ilumya; Sun Pharma) in active psoriatic arthritis (PsA) in adults. https://t.co/cwqz9DoWsL https://t.co/ut0A4MwqW7 4. TYK2 Inhibitor Deucravacitinib FDA Approved for Psoriatic Arthritis On Friday, March 6th, the FDA approved deucravacitinib (Sotyktu) for the treatment of adults with active PsA based on the results of the pivotal Phase 3 POETYK PsA-1 and POETYK PsA-2 clinical trials. https://t.co/a6rmortnoS 5.vUCB announced topline results of the BE-BOLD head-to-head study where bimekizumab (IL-17i) was superior to risankizumab (IL-23i) study; 553 active PsA in achieving an ACR50 response at 16 weeks. Enrolled PsA pts were either bilogic naïve or who had previous exposure to 1 TNFi 6. Retrospective TriNetX Network cohort study of adult PsA (N 123,031) pts, propensity- matched to non-PsA controls. PsA had signif higher CV morbidity: MACE (HR 1.74); mortality (HR 1.95); CHF (HR 1.96), MI (HR 1.71), & CVA (HR 1.49). bDMARDs reduced MACE (HR 0.95) & mortality (HR 0.92) vs csDMARDs   https://t.co/bHrq9KpwBM 7. Prevalence of fibromyalgia in PsA = 18%. FM-PsA pts have higher scores Dz activity scores from FM, rather than inflammation. Fibromyalgia is assoc w/ worse disease outcomes, including failure to achieve low disease activity state and poorer response to therapy. https://t.co/utQRXPmpDs 8. JAMA Patient Education Page on JAMA Eosinophilic Fasciitis (EF). EF is rare, but begins with swelling and redness of the arms and/or legs. Later the skin thickens and develops the peau d' orange appearance. EF does not involve fingers or toes, & doesnt have Raynauds https://t.co/WEFFITtmQC 9. REVEAL, a 5-yr real-world study of 236 SLE pts initiating anifrolumab (basekbube SLEDAI-2K 7 for mucocutaneous (67%) & MSK (49%) dz. At 6 months, 26% achieved remission, 66% reached LLDAS, and 57% achieved LLDAS5. Authors claim rapid onset of action https://t.co/16OQatOcPj https://t.co/mU9aciCNcH 10. Update on FDA complete response letter to AZ regarding BLA hold for anifrolumab (Saphnelo) for SC use in SLE. CRL originally issued 10/10/25, but announced 2/3/26. FDA CRL cites critical data quality w/ key analyses in SC-TULIP study. A BLA decision expected in 1st half of 2026 https://t.co/zuwtsdL6I9 11. NEJM: Obinutuzumab in Active Systemic Lupus Erythematosus https://rheumnow.com/news/nejm-obinutuzumab-active-systemic-lupus-erythematosus

Registered dietitian nutritionist Leyla Muedin discusses a New England Journal of Medicine paper (July 2024, cited via Holistic Primary Care) warning about drug-induced magnesium depletion, especially from diuretics, proton pump inhibitors (e.g., Nexium, Prilosec), and certain antibiotics. She notes magnesium is often not routinely measured despite links between deficiency and cardiovascular, metabolic, and neurological problems, including arrhythmias (AFib, long QT, torsades), endothelial dysfunction, and longer ICU stays. Prevalence estimates range from 7–11% (up to 20%) in hospitalized patients and 2–4% among outpatients, with higher rates among long-term PPI and diuretic users. She reviews symptoms and causes, explains limits of serum magnesium testing, highlights associations with diabetes, alcohol use, low potassium and calcium, and outlines evaluation options and oral repletion approaches, favoring better-absorbed forms like magnesium glycinate over oxide due to diarrhea risk.

Episode 216: Fibromyalgia Overview Reitta Wyllie and Tejasvi Ayaggari (medical students) discuss with Dr. Arreaza the presentation, diagnosis and management of fibromyalgia, a commonly unrecognized disease that may impact patient's quality of life if left untreated.   Written by Reitta Nash, MSIV, American University of the Caribbean. Additional commentary provided by Dr. Tejasvi Ayyagari.  Edits and comments by Hector Arreaza, MD. You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice. Introduction Fibromyalgia is a chronic pain condition that affects millions of people worldwide, yet it remains one of the most misunderstood disorders in medicine. Patients often experience widespread pain, fatigue, sleep disturbances, cognitive difficulties, and a host of other symptoms that significantly impact daily functioning and quality of life.  TJ: It's common, but I feel it is mostly misunderstood and sometimes goes undiagnosed. Reitta: Yes, despite its prevalence, fibromyalgia has historically been met with skepticism, delayed diagnosis, and stigma. Today, we'll break down what fibromyalgia is, what we know about its underlying mechanisms, how it's diagnosed, and how it's managed using evidence-based approaches. What is fibromyalgia? Fibromyalgia is a chronic pain disorder characterized by widespread musculoskeletal pain, accompanied by symptoms such as fatigue, non-restorative sleep, cognitive dysfunction often referred to as “fibro/brain fog,” and mood disturbances. TJ: Unlike inflammatory or autoimmune diseases, fibromyalgia does not cause structural damage to joints or muscles, nor does it produce objective findings on imaging or routine laboratory testing. Instead, it is considered a centralized pain disorder, meaning pain processing within the central nervous system is altered. Arreaza: Many years ago, I had a patient who had fibromyalgia in Germany. He shared how hard it was for him to get diagnosed and treated because many countries fail to recognize fibromyalgia as a disease. However, Germany is not one of them. The German Association of the Medical Scientific Societies (AWMF) has established specific diagnostic criteria for fibromyalgia syndrome (FMS). Also, the World Health Organization recognizes fibromyalgia as a chronic condition, and it is included in the International Classification of Diseases 10th edition (ICD-10). Reitta: The American College of Rheumatology (ACR) recognizes fibromyalgia as a distinct clinical diagnosis, affecting approximately 2–4% of the population, with a higher prevalence in women, though it can affect individuals of any sex or age. Historical Perspective Fibromyalgia was once referred to by terms such as fibrositis, a name that implied inflammation of connective tissue. However, as research failed to demonstrate inflammatory changes, the terminology evolved. In 1990, the American College of Rheumatology introduced the first formal diagnostic criteria, which focused heavily on tender point examination. Over time, these criteria were revised as understanding of the condition improved. Modern diagnostic criteria no longer rely on tender points and instead emphasize symptom severity and widespread pain distribution, reflecting a more patient-centered and clinically practical approach. What causes fibromyalgia? The exact cause of fibromyalgia is not fully understood, but current evidence supports a multifactorial, neurobiological model. The American Academy of Family Physicians identifies a spectrum of chronic overlapping pain conditions that frequently coexist with fibromyalgia, including IBS, TMJ pain, vulvodynia, Chronic fatigue syndrome, interstitial cystitis, endometriosis, chronic tension headaches, migraine, and chronic low back pain. These functional somatic conditions may represent a single disorder manifesting as pain in different body regions at different times over the life span. _____________________ References: Aaron RV, Ravyts SG, Carnahan ND,et al. Prevalence of depression and anxiety among adults with chronic pain: a systematic review and metaanalysis‑analysis. JAMA Netw Open. 2025;8(3):e250268. doi:10.1001/jamanetworkopen.2025.0268. PMID: 40053352. Bradley LA. Pathophysiologic mechanisms of fibromyalgia and its related disorders. J Clin Psychiatry. 2008;69(Suppl 2):6‑14. PMID: 19962493. doi:10.4088/JCP.v69s02102. Häuser W, Ablin J, Fitzcharles MA, et al. Fibromyalgia. Am Fam Physician. 2023;107(2):158‑166. Häuser W, Fitzcharles MA. Facts and myths pertaining to fibromyalgia. Nat Rev Rheumatol. 2018;14(9):525‑535. PMID: 38607678; doi:10.1038/s41584‑018‑0084‑4. Kleykamp BA, Ferguson MC, McNicol E, et al.The prevalence of psychiatric and chronic pain comorbidities in fibromyalgia: An ACTION systematic review. Semin Arthritis Rheum. 2021;51(1):166‑174. PMID: 33383293. doi:10.1016/j.semarthrit.2020.10.006. Magen E, Tolkin L, Aamar S, et al.Endocrine comorbidities in fibromyalgia. Clin Endocrinol (Oxf). 2025;[Epub ahead of print]. doi:10.xxxx/clinend.2025.xxxxx. Mohabbat AB, Wilkinson JM. Central sensitization: When it is not “all in your head.” Am Fam Physician. 2023;107(1):92‑96. Moscati A, Faucon AB, ArnaizYépez‑Yépez C, et al.Life is pain: Fibromyalgia as a nexus of multiple liability distributions. Am J Med Genet B Neuropsychiatr Genet. 2023;192(2):134‑148. doi:10.1002/ajmg.b.32911. Rivera FA, Munipalli B, Allman ME, et al.A retrospective analysis of the prevalence and impact of associated comorbidities on fibromyalgia outcomes in a tertiary care center. Front Med (Lausanne). 2023;10:1184734. doi:10.3389/fmed.2023.1184734. Sleurs D, Tebeka S, Scognamiglio C, Dubertret C, Le Strat Y. Comorbidities of selfreported fibromyalgia in United States adults: A ‑reported fibromyalgia in United States adults: A crosssectional‑sectional study from the NESARC‑III. Eur J Pain. 2020;24(9):1687‑1698. doi:10.1002/ejp.1619. Winslow BT, Vandal C, Dang L. Fibromyalgia: Diagnosis and management. Am Fam Physician. 2023;107(2):158‑166. PMID: 36791450. Wolfe F, Clauw DJ, Fitzcharles MA, et al. Revisions to the American College of Rheumatology fibromyalgia diagnostic criteria. Arthritis Care Res (Hoboken). 2023;75(12):2029‑2039. PMID: 41097025. doi:10.1002/acr.24963. Wolfe F, Clauw DJ, Fitzcharles MA, et al.Revisions to the American College of Rheumatology fibromyalgia diagnostic criteria. Arthritis Care Res (Hoboken). 2023;75(12):2029‑2039. PMID: 41097025. doi:10.1002/acr.24963. Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

Interview with T. Y. Alvin Liu, MD, author of Prevalence and Health Care Disparities of Retinal Conditions: A Meta-Analysis. Hosted by Neil Bressler, MD. Related Content: Prevalence and Health Care Disparities of Retinal Conditions

Interview with T. Y. Alvin Liu, MD, author of Prevalence and Health Care Disparities of Retinal Conditions: A Meta-Analysis. Hosted by Neil Bressler, MD. Related Content: Prevalence and Health Care Disparities of Retinal Conditions

Oh, you're curious about or into BDSM?You have a mental disorderYou must be unhappyYou had a traumatic childhoodYou're dominant? All that means is you cannot take no for an answer. Oh, I'm sorry, you're actually submissive? Well, that is just kink slang for someone who cannot make decisions.There are so many myths and misconceptions when it comes to mental health and BDSM, D/S, and kink. These often hurtful fallacies do more than just sting in the moment; they can causesomeone to not embrace a core part of who they are. Plus, they are so common that it is easy to come to believe there must be truths attached to them.This episode dissects the myths using peer-reviewed research, and I promise it is not a boring psych lecture.Find out what the research actually tells us!Please note: While this covers some of the common misconceptions about mental health and BDSM, this is by no means a complete list. The research reflects patterns across populations, not a universal experience. Individual journeys vary, and that is worth acknowledging.Sources:Wismeijer, A.A. and Van Assen, M.A. "PsychologicalCharacteristics of BDSM Practitioners." Journal of Sexual Medicine (2013) 10:1943Lecuona, O., Martínez-Barajas, O., Gimeno-Martín, A., et al."Not Twisted, Just Kinky: Replication and Structural Invariance of Attachment, Personality, and Well-Being Among BDSM Practitioners." Journal of Sexual Medicine (2025) 72(6):1079-1108Sagarin, B.J., Cutler, B., Cutler, N., et al. "HormonalChanges and Couple Bonding in Consensual Sadomasochistic Activity." Archives of Sexual Behavior (2009) 38:186-200Brown, A., Barker, E.D., Rahman, Q. "A SystematicScoping Review of the Prevalence, Etiological, Psychological, and Interpersonal Factors Associated with BDSM." Journal of Sex Research (2020) 57(6):781-811Holvoet, L., Huys, W., Coppens, V., Seeuws, J., Goethals,K., and Morrens, M. "Fifty Shades of Belgian Gray: The Prevalence of BDSM-Related Fantasies and Activities in the General Population." Journal of Sexual Medicine (2017) 14:1152-1159Pliskin, A.E. "Social and Emotional Intelligence (SEI)in BDSM." Journal of Positive Sexuality (2018) 4(2):48-55Jansen, K.L., Fried, A.L., and Chamberlain, J. "An Examination of Empathy and Interpersonal Dominance in BDSM Practitioners."Journal of Sexual Medicine (2021) 18(3):549-555

Online gambling commercials in the state seem to dominate the television and radio airwaves. Those messages are not lost on our college students. Marshall University Broadcast Journalism senior Abigail Ayes just completed an impactful story about student online gambling for the campus news program, MU Report. Randy Yohe, who is also Ayes' instructor, spoke with the student reporter about her findings. The post The Prevalence Of Student Online Gambling, This West Virginia Morning appeared first on West Virginia Public Broadcasting.

Send a textIn this Journal Club episode, Ben and Daphna review a large cohort study from the Journal of Perinatology on the prevalence and safety of diazoxide in the NICU. With neonatal hypoglycemia seemingly on the rise, they discuss off-label use for transient hyperinsulinism and evaluate real-world data from over 340 Pediatrix units. They dive into the rates of concurrent diuretic therapy, respiratory support, and the dreaded risk of pulmonary hypertension. Tune in for a clinical breakdown of when and how this medication is being utilized across centers, plus Ben's echocardiography struggles with cranky term babies on diazoxide!----Prevalence and safety of diazoxide in the neonatal intensive care unit. Collins LC, Daniel KB, Tolia VN, Parikh P, Gray KD, Greenberg RG.J Perinatol. 2026 Feb 3. doi: 10.1038/s41372-026-02568-2. Online ahead of print.PMID: 41634357Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

We catch up with an old friend - Dr Iain Dutia to discuss all things fatigue.Understanding cognitive fatigue in people with cerebral palsyA continuing series from Oceania Conference 2026 - live from Hobart, Tasmania, Australia.

It's officially Day 1 of the Oceania 2026 Conference - live from Hobart Tasmania, Australia!We catch up with Dr Hayley Smithers Sheedy and Chrissie Macdonald to discuss their paper: Cerebral palsy: temporal trends in birth prevalence in Australia (1995-2018) and epidemiology of people with CP GMFCS IV and V

Philippe Pinel remarked in 1800 that "It is an art of no little importance to administer medicines properly, but it is an art of much greater and more difficult acquisition to know when to suspend or altogether to omit them." This insight remains profoundly relevant today, especially in hospice care, where inappropriate prescribing is a common issue. Studies show that 20%–70% of hospice patients receive at least one unnecessary medication near the end of life, including drugs like antihypertensives, statins, and vitamins. In this episode of the GeriPal Podcast, we tackle the pressing topic of deprescribing at the end of life with expert guests Jennifer Tjia, Jon Furuno, and Simon Mooijaart. The conversation focuses on identifying medications that should almost always be discontinued—such as statins, osteoporosis meds, finasteride, and vitamins, which offer minimal benefit for patients with limited life expectancy. We also delve into more nuanced cases, such as antithrombotics, which present complex decisions that challenge clinicians, particularly when prognosis spans the many weeks to months range. Finally, we explore practical strategies for engaging patients and families in deprescribing conversations. Our guests highlight tools such as the FRAME mnemonic (Focus on the goals of care, Review current medications, Assess each medication's risk/benefit, Minimize the medication burden, and Evaluate regularly) and the Goal Concurrent Prescribing tool, which helps ensure medication decisions align with patients' values and end-of-life priorities. By: Eric Widera Other resources discussed in the podcast Prevalence and Factors Associated With Receiving a Prescription for Antithrombotic Therapy on Hospice Admission," JAGS. 2025 Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-limiting Disease. 2025 Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial. 2024 Perspectives on deprescribing in palliative care. Expert Review of Clinical Pharmacology. 2023 Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study. Thrombosis Research. 2025 Human-Centered Design Development and Acceptability Testing of a Goal Concordant Prescribing Program in Hospice. JPM 2025 Reduction of Antihypertensive Treatment in Nursing Home Residents. NEJM 2025  

Dr. Olivier de Hon is the Chief Science Officer and Director of Intelligence and Investigations at Doping Authority Netherlands. In this episode, he shares more about the history of the organization, progress in estimating doping prevalence, challenges in assessing the effectiveness of anti-doping programs, and considerations for promoting clean sport among elite athletes as well as recreational athletes in gyms and fitness centers.

PeDRA Fellow Hannah Chang hosts a roundtable discussion with Dr. Jillian Rork and Dr. Deepti Gupta about a recent publication titled: Prevalence and Demographics of Psoriasis in the Down Syndrome Population: A Cross-Sectional Analysis Using the Epic Cosmos Dataset. This article was published in the Journal of the American Academy of Dermatology in September 2025.Tell us about you by taking this 1-question survey!

In this episode of The CIRS Group podcast, Barbara and Jacie talk about the prevalence of Chronic Inflammatory Response Syndrome (CIRS). Despite being relatively unknown, CIRS is not rare; It  affects approximately 25% of the population due to genetic susceptibility. They discuss the reasons behind the lack of awareness in conventional medicine, from underdiagnosis and nonspecific symptoms, to larger systemic issues with the medical industry and lack of awareness around mold. This episode highlights who should consider CIRS, the symptoms to look out for, and the steps to diagnosis and treatment. With a mix of personal insights and factual information, this episode aims to arm listeners with the knowledge to make informed decisions about their health. For more information and support, join us at https://thecirsgroup.com Timestamps 00:00 Introduction and medical disclaimer 00:36 What is Chronic Inflammatory Response Syndrome (CIRS)? 01:36 Why don't people take mold seriously? 02:55 Why it's difficult to diagnose CIRS 05:22 Prevalence of CIRS and Genetic Susceptibility 10:11 Exposure sources and triggers for illness 11:22 Common misconceptions and normalization, rationalization 15:24 Who should consider CIRS as a potential diagnosis? 19:31 Conclusion and Resources For more information and support, join us at https://thecirsgroup.com HELPFUL LINKS What even is CIRS? episode: https://youtu.be/K-rztn5x7_w?si=kbmVdeVXx8mLLWu7 Order Jacie's book! The 30 Day Carnivore Bootcamp: https://a.co/d/7MgHrRs The CIRS Group: Support Community: https://thecirsgroup.com Instagram: https://www.instagram.com/thecirsgroup/ Find Jacie for carnivore, lifestyle and limbic resources: Jacie's book on the Carnivore diet!  https://a.co/d/8ZKCqz0 Instagram: https://www.instagram.com/ladycarnivory YouTube: https://www.youtube.com/@LadyCarnivory Blog: https://www.ladycarnivory.com/ Find Barbara for business/finance tips and coaching: Website: https://www.actlikebarbara.com/ Instagram: https://www.instagram.com/actlikebarbara/ YouTube: https://www.youtube.com/@actlikebarbara Jacie is a Shoemaker certified Proficiency Partner, NASM certified nutrition coach, author, and carnivore recipe developer determined to share the life changing information of carnivore and CIRS to anyone who will listen. Barbara is a business and fitness coach, CIRS and ADHD advocate, writer, speaker, and a big fan of health and freedom. Together, they co-founded The CIRS Group, an online support community to help people that are struggling with their CIRS diagnosis and treatment.

While the term "hyperpalatable" has been used frequently for considerable time to refer to foods that are so appealing and tasty that they drive overeating, this term hasn't been well-defined nor has there been a universal standard for what it means. One researcher who set out to create an objective definition for hyper-palatable foods (HPFs) is Dr. Tera Fazzino. Using specific defined thresholds of sugar, fat and salt combinations, Dr. Fazzino and colleagues have looked at the impact of consumption of these HPFs. In this episode, we delve into defining HPFs and their nutrient profiles, whether they have addictive-like properties, how HPFs differ from (and overlap with) ultra-processed foods (UPFs), the mechanisms by which these foods drive overconsumption, and the broader public health implications. Tera Fazzino, PhD, is an associate professor of psychology at the University of Kansas. Her research focuses on addiction, obesity, and eating-related behaviors. Timestamps [03:39] Interview begins [05:05] Attempting to define hyper palatability [10:03] Nutrient combinations in hyper palatable foods [14:54] Prevalence of hyper palatable foods [17:43] Debate on ultra processed foods [30:02] Mechanisms behind hyper palatability [35:06] Addiction theory and hyper-palatable foods [43:38] Early exposure and long-term effects [50:53] Key ideas recap Related Resources Go to episode page (with links to studies mentioned) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-470 Overview: Social media use is nearly ubiquitous among adolescents, raising concern about its role in rising rates of depression, anxiety, insomnia, and suicidality. Although prior evidence has been mixed, emerging studies offer new insights on the relationship between social media use and adolescent mental health. Join us as we review current literature and discuss potential strategies to mitigate negative impacts and improve outcomes. Episode resource links: Calvert E, Cipriani M, Dwyer B, et al. Social Media Detox and Youth Mental Health. JAMA Netw Open. 2025;8(11):e2545245. doi:10.1001/jamanetworkopen.2025.45245 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2840489   Clayborne ZM, Capaldi CA, Mehra VM. Associations between digital media use behaviours, screen time and positive mental health in youth: results from the 2019 Canadian Health Survey on Children and Youth. BMC Public Health. 2025;25(1):2303. Published 2025 Jul 3. doi:10.1186/s12889-025-22874-2 Grøntved A, Singhammer J, Froberg K, et al. A prospective study of screen time in adolescence and depression symptoms in young adulthood. Prev Med. 2015;81:108-113. doi:10.1016/j.ypmed.2015.08.009 Nagata JM, Memon Z, Talebloo J, et al. Prevalence and Patterns of Social Media Use in Early Adolescents. Acad Pediatr. 2025;25(4):102784. doi:10.1016/j.acap.2025.102784 Oberle E, Ji XR, Kerai S, Guhn M, Schonert-Reichl KA, Gadermann AM. Screen time and extracurricular activities as risk and protective factors for mental health in adolescence: A population-level study. Prev Med. 2020;141:106291. doi:10.1016/j.ypmed.2020.106291 Pieh C, Humer E, Hoenigl A, et al. Smartphone screen time reduction improves mental health: a randomized controlled trial. BMC Med. 2025;23(1):107. Published 2025 Feb 21. doi:10.1186/s12916-025-03944-z Riehm KE, Feder KA, Tormohlen KN, et al. Associations Between Time Spent Using Social Media and Internalizing and Externalizing Problems Among US Youth. JAMA Psychiatry. 2019;76(12):1266–1273. doi:10.1001/jamapsychiatry.2019.2325 Varona MN, Muela A, Machimbarrena JM. Problematic use or addiction? A scoping review on conceptual and operational definitions of negative social networking sites use in adolescents. Addict Behav. 2022;134:107400. doi:10.1016/j.addbeh.2022.107400 Woolf SH. The Youth Mental Health Crisis in the United States: Epidemiology, Contributors, and Potential Solutions. Pediatrics. 2025;156(5):e2025070849. doi:10.1542/peds.2025-070849 Xiang AH, Martinez MP, Chow T, et al. Depression and Anxiety Among US Children and Young Adults. JAMA Netw Open. 2024;7(10):e2436906. doi:10.1001/jamanetworkopen.2024.36906 BBC: Australia has banned social media for kids under 16. How will it work? https://www.bbc.com/news/articles/cwyp9d3ddqyo Guest: Susan Feeney, DNP, FNP-BC, NP-C   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Welcome to the Social-Engineer Podcast: The Doctor Is In Series – where we will discuss understandings and developments in the field of psychology.    In today's episode, Chris and Dr. Abbie explore imposter syndrome, examining what it is, why it occurs, and how cultural and professional pressures can intensify it. They discuss common symptoms, personal experiences, and the psychological roots behind feeling undeserving of success. Through scientific insight and practical strategies, they share ways to recognize, reframe, and manage imposter syndrome with greater self-awareness and confidence.  [Feb 2, 2026]  00:00 - Intro  00:20 - Meet the Hosts  00:54 - Upcoming Events and Announcements  02:29 - Defining Imposter Syndrome  06:42 - Cultural and Gender Influences  12:26 - Personality Traits and Imposter Syndrome  14:46 - Sponsor  16:12 - Balancing Humility and Confidence  19:34 - Strategies to Overcome Imposter Syndrome  27:02 - Billy Boatwright's Story  30:36 -  Conclusion and Next Episode Preview    Find us online:   LinkedIn: linkedin.com/in/dr-abbie-maroño-phd   Instagram: @DoctorAbbieofficial   LinkedIn: linkedin.com/in/christopherhadnagy     References:  Beck, J. S. (2011). Cognitive behavior therapy: Basics and beyond (2nd ed.). Guilford Press.   Bennett-Levy, J., Butler, G., Fennell, M., Hackmann, A., Mueller, M., & Westbrook, D. (2004). The Oxford guide to behavioral experiments in cognitive therapy. Oxford University Press.   Breines, J. G., & Chen, S. (2012). Self-compassion increases self-improvement motivation. Personality and Social Psychology Bulletin, 38(9), 1133–1143. https://doi.org/10.1177/0146167212445599   Bravata, D. M., Watts, S. A., Keefer, A. L., Madhusudhan, D. K., Taylor, K. T., Clark, D. M., Nelson, R. S., Cokley, K. O., & Hagg, H. K. (2020). Prevalence, predictors, and treatment of impostor syndrome: A systematic review. Journal of General Internal Medicine, 35(4), 1252–1275. https://doi.org/10.1007/s11606-019-05364-1   Clance, P. R. (1985). The impostor phenomenon: Overcoming the fear that haunts your success. Peachtree Publishers.   Clance, P. R., & Imes, S. A. (1978). The impostor phenomenon in high achieving women: Dynamics and therapeutic intervention. Psychotherapy: Theory, Research and Practice, 15(3), 241–247. https://doi.org/10.1037/h0086006   Edmondson, A. (1999). Psychological safety and learning behavior in work teams. Administrative Science Quarterly, 44(2), 350–383. https://doi.org/10.2307/2666999  

Avoidant restrictive food intake disorder (ARFID) is an eating disorder where people severely restrict food due to fear, sensory sensitivities, or low interest — not body image concerns — causing significant health and social problems Unlike normal picky eating, ARFID involves intense distress, extremely narrow food choices, nutritional deficiencies, weight loss, and serious disruption to daily life and social activities Prevalence ranges from 0.35% to 6.4% depending on region, primarily affecting children and teens, with average diagnosis at age 11 and higher male representation than other disorders Treatment approaches include parental control strategies, cognitive behavioral therapy, family-based treatment, food therapy, and sequential oral sensory methods to gradually reduce food-related fear and anxiety A specialized protocol combining psychology, hypnosis, and neuro-linguistic programming shows 90% success for adults and 65% for children, often achieved in single session

Avoidant restrictive food intake disorder (ARFID) is an eating disorder where people severely restrict food due to fear, sensory sensitivities, or low interest — not body image concerns — causing significant health and social problems Unlike normal picky eating, ARFID involves intense distress, extremely narrow food choices, nutritional deficiencies, weight loss, and serious disruption to daily life and social activities Prevalence ranges from 0.35% to 6.4% depending on region, primarily affecting children and teens, with average diagnosis at age 11 and higher male representation than other disorders Treatment approaches include parental control strategies, cognitive behavioral therapy, family-based treatment, food therapy, and sequential oral sensory methods to gradually reduce food-related fear and anxiety A specialized protocol combining psychology, hypnosis, and neuro-linguistic programming shows 90% success for adults and 65% for children, often achieved in single session